Sign In
Buy TAK
$15.03
-0.150 (-0.99%)
At Close: Jun 03, 2026
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
07:51am, Thursday, 26'th Aug 2021
Exelixis Inc's (NASDAQ: EXEL) collaborating partner Takeda Pharmaceutical Co Ltd (NYSE: TAK) and Ono Pharmaceutical Co Ltd have received approval for Cabometyx (cabozantinib) in Japan. The appr
Takeda: A Pharmaceutical Gem From Japan
07:54pm, Monday, 23'rd Aug 2021
Takeda: A Pharmaceutical Gem From Japan
BioLife Plasma Services Opens First All-Electric Plasma Donation Center
11:00am, Wednesday, 18'th Aug 2021
TUKWILA, Wash.--(BUSINESS WIRE)--BioLife Plasma Services Opens First All-Electric Plasma Donation Center
Takeda To Lead Finch-Partnered Microbiome IBD Drug
03:54pm, Tuesday, 10'th Aug 2021
Finch Therapeutics Group Inc (NASDAQ: FNCH) announced that Takeda Pharmaceutical Company Limited (NYSE: TAK) has elected to take the lead on the development of FIN-524, now known as TAK-524, in ulc
5%-Yielding Takeda Pharma Could Triple In 5 Years
07:00am, Saturday, 07'th Aug 2021
What if I told you there was a blue chip that was offering a safe 5% yield yet was 45% undervalued? Here are the three reasons why Takeda Pharma might be just the thing you need to enjoy generous yiel
4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows
07:35am, Wednesday, 04'th Aug 2021
It has become the proverbial broken record. Every time it seems like yields on government securities will start trending higher, they roll over again.
Takeda Pharmaceutical: 5% Dividend Yield With Bullish Catalysts This Year
09:03am, Tuesday, 03'rd Aug 2021
Takeda Pharmaceutical: 5% Dividend Yield With Bullish Catalysts This Year
Takeda to record 63 billion yen provision, update Q1 results on Irish tax issue
09:10pm, Sunday, 01'st Aug 2021
Takeda Pharmaceutical Co said on Monday it will record a provision of about 63 billion yen ($574.56 million) in its financial statements for the first quarter to reflect a decision by Ireland's tax ap
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
07:30pm, Sunday, 01'st Aug 2021
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30, 2021 (
Takeda Pharmaceutical Co Ltd (TAK) CEO Christophe Weber on Q1 2022 Results - Earnings Call Transcript
12:25am, Saturday, 31'st Jul 2021
Takeda Pharmaceutical Co Ltd (TAK) CEO Christophe Weber on Q1 2022 Results - Earnings Call Transcript
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic Vaccines Takeda Will Focus its Efforts on Dengue, Zika and Pandemic Vaccines
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced financial results for the first quarter of fiscal year 2021 (period ended June
CAMBRIDGE, Mass. & MENLO PARK, Calif.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) granted Brea
Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
03:00pm, Tuesday, 20'th Jul 2021
OSAKA, Japan--(BUSINESS WIRE)--Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
